Funds holding “TEVA PHARMACEUTICAL FINANCE NETHERLANDS III BV”
Which closed-end funds own a security? Searches the latest N-PORT snapshot of every active fund. Enter a ticker (issuer-level: matches the vendor-mapped ticker), a CUSIP or ISIN (security-level: one specific bond or share class), or part of a name.
26 positions across 14 funds, 6 distinct securities (bonds, share classes and derivatives of the same issuer are listed separately). Weights are percent of net assets from each fund’s latest N-PORT; report dates differ by fund.
| Fund | Position | Identifier | Type | Weight | Value (USD) | Report date | Coverage |
|---|---|---|---|---|---|---|---|
| HYI Western Asset High Yield Opportunity Fund High Yield | TEVA PHARMACEUTICAL FINANCE NETHERLANDS III BV | 88167AAQ4 | DBT | 1.09% | $1.6M | May 29, 2026 | full (281 positions) |
| EHI Western Asset Global High Income Fund High Yield | TEVA PHARMACEUTICAL FINANCE NETHERLANDS III BV | 88167AAT8 | DBT | 0.77% | $2.1M | May 29, 2026 | full (396 positions) |
| EMD Western Asset Emerging Markets Debt Fund Taxable Bonds | TEVA PHARMACEUTICAL FINANCE NETHERLANDS III BV | 88167AAE1 | DBT | 0.76% | $6.5M | Jun 30, 2026 | full (260 positions) |
| HIO Western Asset High Income Opportunity Fund High Yield | TEVA PHARMACEUTICAL FINANCE NETHERLANDS III BV | 88167AAF8 | DBT | 0.54% | $2M | Jun 30, 2026 | full (325 positions) |
| HIX Western Asset High Income Fund II High Yield | TEVA PHARMACEUTICAL FINANCE NETHERLANDS III BV | 88167AAQ4 | DBT | 0.53% | $2.7M | Jul 31, 2026 | full (397 positions) |
| HIX Western Asset High Income Fund II High Yield | TEVA PHARMACEUTICAL FINANCE NETHERLANDS III BV | 88167AAE1 | DBT | 0.49% | $2.5M | Jul 31, 2026 | full (397 positions) |
| HYI Western Asset High Yield Opportunity Fund High Yield | TEVA PHARMACEUTICAL FINANCE NETHERLANDS III BV | 88167AAF8 | DBT | 0.47% | $702K | May 29, 2026 | full (281 positions) |
| EMD Western Asset Emerging Markets Debt Fund Taxable Bonds | TEVA PHARMACEUTICAL FINANCE NETHERLANDS III BV | 88167AAF8 | DBT | 0.36% | $3.1M | Jun 30, 2026 | full (260 positions) |
| IGI Western Asset Investment Grade Opportunity Trust Investment Grade | TEVA PHARMACEUTICAL FINANCE NETHERLANDS III BV | 88167AAR2 | DBT | 0.34% | $361K | May 29, 2026 | full (426 positions) |
| WEA Western Asset Premier Bond Fund Taxable Bonds | TEVA PHARMACEUTICAL FINANCE NETHERLANDS III BV | 88167AAQ4 | DBT | 0.34% | $646K | Jun 30, 2026 | full (384 positions) |
| WDI Western Asset Diversified Income Fund (WDI) Multi-Asset | TEVA PHARMACEUTICAL FINANCE NETHERLANDS III BV | 88167AAF8 | DBT | 0.31% | $2.3M | Jun 30, 2026 | full (473 positions) |
| HIO Western Asset High Income Opportunity Fund High Yield | TEVA PHARMACEUTICAL FINANCE NETHERLANDS III BV | 88167AAT8 | DBT | 0.30% | $1.1M | Jun 30, 2026 | full (325 positions) |
| PPT Franklin Premier Income Trust Taxable Bonds | Teva Pharmaceutical Finance Netherlands III BV | 88167AAR2 | DBT | 0.28% | $1.1M | Jul 31, 2026 | full (769 positions) |
| HIX Western Asset High Income Fund II High Yield | TEVA PHARMACEUTICAL FINANCE NETHERLANDS III BV | 88167AAT8 | DBT | 0.27% | $1.4M | Jul 31, 2026 | full (397 positions) |
| PIM Franklin Master Intermediate Income Trust Investment Grade | Teva Pharmaceutical Finance Netherlands III BV | 88167AAR2 | DBT | 0.25% | $506K | Jun 30, 2026 | full (734 positions) |
| EHI Western Asset Global High Income Fund High Yield | TEVA PHARMACEUTICAL FINANCE NETHERLANDS III BV | 88167AAE1 | DBT | 0.25% | $697K | May 29, 2026 | full (396 positions) |
| HIO Western Asset High Income Opportunity Fund High Yield | TEVA PHARMACEUTICAL FINANCE NETHERLANDS III BV | 88167AAQ4 | DBT | 0.24% | $880K | Jun 30, 2026 | full (325 positions) |
| EMD Western Asset Emerging Markets Debt Fund Taxable Bonds | TEVA PHARMACEUTICAL FINANCE NETHERLANDS III BV | 88167AAR2 | DBT | 0.22% | $1.8M | Jun 30, 2026 | full (260 positions) |
| FT Franklin Universal Trust U.S. Equity | Teva Pharmaceutical Finance Netherlands III BV | 88167AAP6 | DBT | 0.21% | $601K | May 31, 2026 | full (675 positions) |
| GDO Western Asset Global Corporate Opportunity Fund Multi-Asset | TEVA PHARMACEUTICAL FINANCE NETHERLANDS III BV | 88167AAE1 | DBT | 0.20% | $239K | Jul 31, 2026 | full (313 positions) |
| PAI Western Asset Investment Grade Income Fund Investment Grade | TEVA PHARMACEUTICAL FINANCE NETHERLANDS III BV | 88167AAR2 | DBT | 0.18% | $226K | Jun 30, 2026 | full (473 positions) |
| FT Franklin Universal Trust U.S. Equity | Teva Pharmaceutical Finance Netherlands III BV | 88167AAR2 | DBT | 0.12% | $339K | May 31, 2026 | full (675 positions) |
| WEA Western Asset Premier Bond Fund Taxable Bonds | TEVA PHARMACEUTICAL FINANCE NETHERLANDS III BV | 88167AAF8 | DBT | 0.08% | $154K | Jun 30, 2026 | full (384 positions) |
| HIX Western Asset High Income Fund II High Yield | TEVA PHARMACEUTICAL FINANCE NETHERLANDS III BV | 88167AAF8 | DBT | 0.07% | $354K | Jul 31, 2026 | full (397 positions) |
| GDO Western Asset Global Corporate Opportunity Fund Multi-Asset | TEVA PHARMACEUTICAL FINANCE NETHERLANDS III BV | 88167AAF8 | DBT | 0.06% | $73.8K | Jul 31, 2026 | full (313 positions) |
| SCD LMP Capital & Income Fund U.S. Equity | TEVA PHARMACEUTICAL FINANCE NETHERLANDS III BV | 88167AAT8 | DBT | 0.04% | $208K | May 29, 2026 | full (169 positions) |
Matching position names
TEVA PHARMACEUTICAL FINANCE NETHERLANDS III BV · 22Teva Pharmaceutical Finance Netherlands III BV · 4
Historical holdings reports are not a real-time portfolio. Security-level matching (CUSIP/ISIN) distinguishes a company’s bonds, common shares, preferreds and derivatives; issuer-level matching groups them by name or ticker and is labelled as such. See the overlap tool to compare two portfolios.